PHIO

Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches

Phio Pharma's PH-762 Shows Encouraging Antitumor Efficacy In Preclinical Studies

4 Hot Reddit Penny Stocks With Higher Than Average Volume

Phio Pharmaceuticals Announces Upcoming Data Presentations at the ASGCT and ASCO Annual Meetings

Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting PD-1

Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update

PHIO Stock Price Increases Over 10% Pre-Market: Why It Happened